Conduct a Study with Us
Visit Our Clinical Research Facility in Roseville, CA
Our organization is built on excellence and experience and we are paving the way for a bright future of research medicine in the Greater Sacramento area.
Why work with us
Advantages of working with DaVinci Research
DaVinci Research (DVR) simplifies and streamlines the process and responsibilities of being an investigator.
Site capabilities (On-Site)
we have collaborated where needed with the following specialists/services
Past Conditions Researched
Efficacy Trial of BHV-3000 for Acute Treatment of Chronic Rhinosinusitis (CRS) With or Without Nasal Polyps.
A Phase II Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LYR-220 in Chronic Rhinosinusitis (CRS) Patients Who Have Had a Prior Ethmoidectomy
Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation
LYR-210-2021-004- ENLIGHTEN 1
A Phase III Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in adults.
Assessing Long-Term Outcomes of DUPIXENT® Treatment in Patients with Chronic Rhinosinusitis with Nasal Polyposis (AROMA)
2-part study to evaluate the efficacy and safety of Dupilumab in patients with uncontrolled, chronic rhinosinusitis without nasal polyposis (CRSsNP)
Hear from Our Site & Sponsors
As a sponsor selecting sites, we often have to make difficult choices between academic research centers that bring domain specific knowledge but are slow to enroll study subjects, non-academic practices that may not have staff that is adequately trained in the execution of clinical trials, or clinical research organizations which may not be able to bring in a high volume but with less domain experience, and certainly no long-term relationship with enrolled study subjects. Using Sacramento ENT for clinical research, we get the benefits of domain specific knowledge , high enrollment, adequately trained staff and investigators that have a vested interest in the long-term care of the study subjects.
Your team brings the best combination of what as a sponsor, we need in the execution of quality clinical trials. We need more sites like yours in the ENT industry.
Thank you for your continued support of our current studies and those we hope to partner with you in the future.
In addition, we appreciate your insightful comments at our recent Investigator Meeting regarding the centralized reading of nasal polyps scores and other trial factors. It's been a pleasure to work with you, and we will look forward to further contributions from your site.
On behalf of my entire team, I wanted to personally thank you for your partnership in our clinical programs over the years. Under Dr Ow's and your leadership, together we have established a new standard for clinical science in the Otolaryngology field. Conducting multicenter, randomized, controlled studies were no the norm in ENT when we started working with you and like-minded clinicians years ago. It is clinical sites like yours that have the tenacity, capabilities and ability to deliver high quality data that have made these advancements possible. Thank you.
Please pass on our congratulations and thanks to the entire team. We so appreciate your strong patient relationships, hard work, and attention to detail. We literally couldn't do what we do without you and the Sacramento ENT team.
We also selected Sac ENT because we were familiar with you and your team's skills in supporting new technology research and had confidence that, through your management of the studies, the study conduct and documentation would be compliant with FDA regulations and IRB requirements and would pass FDA's scrutiny during an audit. We appreciate the level of professionalism and compassion that you and Marcy Adame demonstrate through your patient interactions during the research process including consenting , procedure and study visits. Marcy and Oleg Kolesnikov also do an excellent job in data collection and regulatory documentation in a manner that will withstand an FDA audit, and in management of the study product and logistics.
A special note of a appreciation to you and Marcy, for being so responsive for all the necessary communications regarding study conduct, scheduling and logistics, and to Dr Ow for never hesitating to reach out to us directly with any questions or concerns.
We look forward to continuing to work with you in the OTTER in future studies.
This letter is to recognize Dr. Ow and his clinical research team's significant contributions to the Beacon study.
Congratulations on being the top enroller in Beacon! On behalf of Lyra, I would like to congratulate you and your research team on this accomplishment. Lyra Therapeutics' clinical team is grateful for the collaboration.
Committed to Diveristy in Patient Recruitment
One of our main goals here at DaVinci Research is our commitment to diverse patient recruitment practices. We believe that inclusion is the best way to find results that work for everyone.
our Dedicated Team
Meet Dr. Ow's Dynamic Research Team at DaVinci Research
With an unwavering passion for exploration and discovery, Dr. Ow’s exceptional team at DaVinci Research is pushing the boundaries of knowledge in their groundbreaking research projects.